Back to Swiss National Bank Swiss National Bank

ARWRARWR
Showing 8 of 31 quarters

Position history for Swiss National BankSwiss National Bank's holdings in ARROWHEAD PHARMACEUTICALS IN

Swiss National Bank holds 238,900 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $19.5M as of 2026-Q2. The position was decreased (-1.3% shares). ARWR represents 0.0% of Swiss National Bank's portfolio.

Current Value

$19.5M

Current Shares

238,900

Total Value Change

+$15.2M

Total Shares Change

+20,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
238,900
-1.3%
$19.5M0.0%$81.51
0
2026-Q1
Decreased
242,000
-1.4%
$15.2M0.0%$64.10
0
2025-Q4
Increased
245,400
+14.6%
$16.3M0.0%$67.25
32
2025-Q3
Increased
214,100
+2.0%
$7.4M0.0%$33.78
28
2025-Q2
Decreased
209,800
-3.3%
$3.3M0.0%$16.08
0
2025-Q1
Decreased
216,900
-1.4%
$2.8M0.0%$13.82
0
2024-Q4
Increased
220,000
+0.8%
$4.1M0.0%$18.61
27
2024-Q3
Decreased
218,300
-10.3%
$4.2M0.0%$19.67
0

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used